Get Alta Partners contact and information in the United States

Investor Type	Firm
Type of Fund	Venture Capital Fund
Industries	Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • Businesses Solutions • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Investment Management • Life Science • Nanotechnology • Oncology • Consumer • Pharmaceutical (& Medicine)
Stages	Seed, Startup, Early Stage, Expansion, Later Stage, PIPE, Series A
Investing	United States
Investment Range	$100,000 - $5,000,000
Investment Sweet Spot	$1,500,000
Assets Under Management	$2,000,000,000

Who are the key investors at Alta Partners?

Who co-invests with Alta Partners?

What is Alta Partners?

Alta Partners is a leading healthcare venture capital firm with its headquarters located at 1 Embarcadero Center, Suite 3700, San Francisco, California. They are dedicated to investing in the life science and healthcare technology sectors.

With a focus on innovation and technology, Alta Partners aims to empower the next generation of healthcare by supporting high-impact companies that challenge the status quo and work towards better outcomes for patients.

The firm invests in a broad range of industries including Software, IT and TMT, BioTech, Business Solutions, HealthTech and Fitness, Medical Devices and Hospital Services, Healthcare and Wellness, Investment Management, Life Science, Nanotechnology, Oncology, Consumer, and Pharmaceutical and Medicine.

Alta Partners operates as a Venture Capital Fund with expertise in equity investments and manages assets worth approximately $2 billion. The fund's investment approach ranges from Seed to Startup, Early Stage, Expansion, Later Stage and PIPE, with investment sweet spot around $1,500,000, a minimum investment of $100,000, and a maximum investment of $5,000,000.

Alta Partners highlights its commitment to discovering and developing novel therapeutics through its portfolio companies, which include Allakos Biopharma focusing on inflammation, DispatchHealth specializing in mobile care, and Vir Biotechnology targeting infectious diseases. These companies exemplify Alta Partners' dedication to not only financial return but also social impact by improving healthcare outcomes.

Alta Partners's investments on record

Esperion Therapeutics	$33,000,000.00	Venture Round
Esperion Therapeutics	$22,800,000.00	Series A
St. George's University	$750,000,000.00	Other
Vir Biotechnology	$150,000,000.00	Later stage VC
Allakos	$100,000,000.00	Later stage VC
Egenesis	$100,000,000.00	Later stage VC
CuraSen	$54,500,000.00	Later stage VC
VertiFlex	$40,000,000.00	Later stage VC
eGenesis	$38,000,000.00	Early stage VC